Novo Nordisk shares plunge on outlook warning as Mounjaro rival races ahead

Wegovy and Ozempic maker Novo Nordisk forecast plunging sales and earnings in 2026, which saw the Danish drugmaker’s shares plummet by nearly a fifth.


28 h. ago
Sport
ID: -679306657137909020


Similar News expand_more


Entertainment
Sport
Sport
Economics
Sport
Sport
Sport
Sport
Sport
Science
Sport
Sport
Sport
Sport
Sport
Entertainment
Politics
Politics
Sport
Sport
Sport
Sport
Sport
Sport
Entertainment
Sport
Politics
Space
Military
Weather
Sport
Sport
Sport
Sport
Politics
Sport
Automotive
Sport
Sport
Real Estate
Sport
Sport
Sport
Politics
Sport
Sport
Sport
Sport
Sport
Sport
Sport
Sport
Sport
Sport
Politics
Sport
Sport
Politics
Sport
Sport
Weather
Sport
Sport
Sport
Sport
Sport
Politics
Politics
Sport
Sport
Politics
Sport
Sport
Sport
Politics
Crime
Sport
Sport
Sport
Sport
Sport
Sport
Entertainment
Entertainment
Sport
Sport
Sport
Military
Sport
Weather
Politics
Sport
Military
Sport
Politics
Sport
Politics
Sport
Travel
Add Watch Country

arrow_drop_down